Related Experiment Video

Updated: Nov 25, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.5K

Killing 2 Cocci With 1 Vaccine: Unleashing the Full Potential of an Adolescent Meningococcal B Immunization Program

Shamez N Ladhani1,2, Ray Borrow3, Mary E Ramsay1,4

  • 1Immunisation and Countermeasures Division, Public Health England, London, United Kingdom.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 19, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
4CMenBadolescent immunisationgonorrhoeameningococcal diseasemeningococcal vaccination

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.6K
Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

12.8K

Related Experiment Videos

Last Updated: Nov 25, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.5K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.6K
Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

12.8K

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

783
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
783

Articles linked to this work by shared authors, journal, and citation graph.

Assessing the risk of Guillain-Barré syndrome in older adults after bivalent RSV pre-F vaccination in England.

Nature communications·2025

Cost-effectiveness of vaccination strategies to control future mpox outbreaks in England: a modelling study.

The Lancet regional health. Europe·2025

The United Kingdom meningococcal vaccine (4CMenB) programme against gonorrhoea: A review of the evidence and knowledge gaps.

The Journal of infection·2025

Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025

An England-wide survey on attitudes towards antenatal and infant immunisation against respiratory syncytial virus amongst pregnant and post-partum women.

Vaccine·2025

Recurrent invasive pneumococcal disease in children: A retrospective cohort study, England, 2006/07-2017/18.

The Journal of infection·2025

Artificial Intelligence-Supported Automated Microscopy for Malaria Diagnosis: A Multicenter Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Antimicrobials in a Box: A Primer on the Risks of Direct-to-Consumer Antimicrobial Preparedness Kits.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Hepatitis B Vaccination for Liver Transplant Recipients in the United States: A National Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Waterborne outbreak of Mycobacterium abscessus in a UK specialist heart and lung hospital 2019-2026: patients, mitigations and implications.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Influenza vaccine effectiveness against influenza A-associated hospitalization and severe in-hospital outcomes among adults in the United States, 2024-2025.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Ethical Priorities for Candida auris Screening in Solid Organ Transplantation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Corrigendum to 'Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial': [RPTH, 103360, January 2026, Volume 10, Issue 1].

Research and practice in thrombosis and haemostasis·2026

INDICATIONS FOR REMOVAL OF A PORT SYSTEM IN A PATIENT WITH SUSPECTED SEPTICEMIA IN THE ABSENCE OF OTHER LOCAL SOURCES OF INFECTION.

Georgian medical news·2026

Beyond Primum Non Nocere: Therapeutic Injury, Comparative Harm Management, and the Ethics of Modern Medicine.

Journal of evaluation in clinical practice·2026

Concurrent Pulmonary Detection of Nocardia beijingensis, Mycobacterium tuberculosis, and Mycobacterium fortuitum in a Liver Transplant Recipient.

Journal of Brown hospital medicine·2026

The therapeutic potential of transposable element activity modulation.

EMBO molecular medicine·2026

TISA-818, an Anti-inflammatory Conjugate of Montelukast-Decapeptide, in Acute Respiratory Distress Syndrome Due to Pulmonary Infection: A Phase 2 Randomized Trial Using the 2023 Global Definition.

Chest·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us